Contribution of liraglutide in the fixed-ratio combination of insulin degludec and liraglutide (IDegLira)

Keyphrases

• Liraglutide 100%
• Insulin Degludec 100%
• Fixed-ratio Combination 100%
• Metformin 13%
• Type 2 Diabetic Patients 9%
• Treatment Difference 4%
• High Risk 4%
• Adverse Events 4%
• Hypoglycemia 4%
• Once-daily 4%
• Glycemic Control 4%
• Nausea 4%
• Fasting Plasma Glucose 4%
• Weight Loss 4%
• Weight Reduction 4%
• Weight Change 4%
• Insulin Dose 4%
• Double-blind Trial 4%
• Basal Insulin 4%
• Hypoglycemia Risk 4%
• Sulfonylurea 4%
• Titration 4%
• Novel Combinations 4%
• Glinides 4%

Pharmacology, Toxicology and Pharmaceutical Science

• Liraglutide 100%
• Insulin Degludec 100%
• Metformin 13%
• Hypoglycemia 9%
• Non Insulin Dependent Diabetes Mellitus 9%
• Adverse Event 4%
• Nausea 4%
• Sulfonylurea 4%